<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 28, 2000
INSMED INCORPORATED
(Exact name of registrant as specified in its charter)
VIRGINIA 0-30739 54-1972729
--------------------------------- ------------ ----------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)
800 East Leigh Street, Richmond, VA 23219
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (804) 828-6893
<PAGE>
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibit.
99.1 Presentation of November 28, 2000.
Item 9. Regulation FD Disclosure.
On November 28, 2000, Insmed Incorporated (the "Company") held a
public conference call with investors. During the call, Dr. Geoffrey Allan,
Chairman of the Board, President and Chief Executive Officer of the Company,
indicated that the slides relating to his prepared remarks would be furnished
for review on the SEC's website. The presentation, which is incorporated
herein by reference, is attached hereto as Exhibit 99.1.
The information in this report (including the exhibit) is furnished
pursuant to Item 9 and shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section. This report will not be deemed an
admission as to the materiality of any information in the report that is
required to be disclosed solely by Regulation FD.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INSMED INCORPORATED
Date: November 30, 2000 By: /s/ Michael D. Baer
__________________________
Michael D. Baer
Chief Financial Officer
3
<PAGE>
INSMED INCORPORATED
INDEX TO EXHIBITS
Exhibit Number
99.1 Presentation of November 28, 2000.
4